KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $131,000 | +4266.7% | 29,111 | +6080.7% | 0.01% | – |
| Q1 2022 | $3,000 | -62.5% | 471 | -62.6% | 0.00% | – |
| Q4 2021 | $8,000 | -87.3% | 1,258 | -88.3% | 0.00% | -100.0% |
| Q3 2021 | $63,000 | +2000.0% | 10,774 | +3503.3% | 0.00% | – |
| Q1 2021 | $3,000 | -85.0% | 299 | -78.3% | 0.00% | -100.0% |
| Q3 2020 | $20,000 | -67.2% | 1,379 | -57.1% | 0.00% | -71.4% |
| Q2 2020 | $61,000 | +190.5% | 3,213 | +194.5% | 0.01% | -22.2% |
| Q1 2020 | $21,000 | +950.0% | 1,091 | +305.6% | 0.01% | +800.0% |
| Q2 2019 | $2,000 | +100.0% | 269 | +232.1% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 81 | -22.9% | 0.00% | -100.0% |
| Q2 2018 | $2,000 | -33.3% | 105 | -68.6% | 0.00% | -50.0% |
| Q4 2017 | $3,000 | – | 334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |